LFB Biomedicaments Received Additional Regulatory Approval in 15 European Countries for Its World Wide Unique Von Willebrand Factor with Low Factor VIII Content: Willfact(R)
12/22/2010 8:28:26 AM
More...
|
Swedish Orphan Biovitrum to Increase the Availability of Willfact(R) to von Willebrand Patients as LFB Biomedicaments Has Received Additional European Regulatory Approvals
12/20/2010 8:51:56 AM
More...
|